Humana (HUM) - FREE Research Report Jones David A Jr/Ky who is Director at Humana sold 11,000 shares at $95.00 on Nov. 12, 2013. Following this transaction, the Director owned 143,339 shares meaning that the stake was reduced by 7.13% with the 11,000 share transaction. The shares most recently traded at $96.40, up $1.40, or 1.45% since the insider transaction. Historical insider transactions for Humana go as follows:
12-Week # shares sold: 1,115
24-Week # shares sold: 54,401
The average volume for Humana has been 1.1 million shares per day over the past 30 days. Humana has a market cap of $15.0 billion and is part of the health care sector and health services industry. Shares are up 40.1% year to date as of the close of trading on Tuesday. Humana Inc., a health care company, offers a range of insurance products, and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in three segments: Retail, Employer Group, and Healthcare Services. The stock currently has a dividend yield of 1.12%. The company has a P/E ratio of 10.6. Currently there are 11 analysts that rate Humana a buy, no analysts rate it a sell, and 6 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on HUM - FREETheStreet Quant Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Humana Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.